Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and...
Source: Pediatric Rheumatology - Category: Rheumatology Authors: Tags: Case Report Source Type: research